Skip to main content

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

MGX holding history

Metagenomi Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MGX overviewAll 13F holders of MGXFull Q2 2026 holdings

Shares (Q2 2026)
12,797
Value
$15.2K
% of portfolio
<0.1%
Quarters held
3
Since Q4 2025
Holdings of MGX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,797$15.2K<0.1%00.0%UnchangedHolders
Q1 202612,797$17.1K<0.1%−986−7.2%ReducedHolders
Q4 202513,783$22.3K<0.1%+13,783NewHolders